Trial Profile
Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Dec 2018
Price :
$35
*
At a glance
- Drugs Tinzaparin sodium (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms STRIP
- 12 Dec 2018 Status changed from active, no longer recruiting to completed.
- 28 Aug 2017 Planned End Date changed from 1 Oct 2016 to 1 Dec 2018.
- 28 Aug 2017 Status changed from recruiting to active, no longer recruiting.